- ParkerVision (OTC:PRKR -3%) had a Q2 net loss of $5.8M, or $0.06/share. Opex totaled $5.9M (-18% Y/Y) - R&D spend fell 13% to $2.2M, and G&A spend 31% to $2.8M (lower legal expenses). (PR)
- No revenue was recorded. ParkerVision ended Q2 with $21.8M in cash/investments, down from $25.3M at the end of Q1.
- On the CC (transcript), CEO Jeffrey L. Parker said ParkerVision continues to "actively evaluate the best ways in which to support the funding" for its battle against Qualcomm, following June's adverse rulings. He adds ParkerVision has multiple options, including one that would lower its legal bill in exchange for "sharing a larger portion of any settlement or award."
- An initial hearing for ParkerVision's appeal of the June rulings is expected "sometime early next year." In the meantime, the company claims it's seeing "good customer reception" for its new RF demodulator ICs, which are aimed in part at the mobile infrastructure market.
- Shares are close to a 52-week low of $1.10, and down 75% YTD.